Arrowpoint Investment Partners »

Alnylam Pharmaceuticals shares owned by Arrowpoint Investment Partners

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Arrowpoint Investment Partners from 13F filings

Historical chart of Arrowpoint Investment Partners investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Arrowpoint Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Arrowpoint Investment Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.7M 5.6k 301.03
2025-03-31 $3.8M 14k 270.02

More positions owned by Arrowpoint Investment Partners

Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Citigroup Com New (C)
Goldman Sachs (GS)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Global Payments (GPN)
Norfolk Southern (NSC)
American Electric Power Company (AEP)
NVIDIA Corporation (NVDA)
Exxon Mobil Corporation (XOM)
Ishares Msci Sth Kor Etf Put Option (EWY)
Ishares Msci Taiwan Etf (EWT)
Alphabet Cap Stk Cl A (GOOGL)
Micron Technology (MU)
Ishares Tr Expanded Tech Call Option (IGV)
Intel Corporation (INTC)

View all positions for Arrowpoint Investment Partners

Top funds holding Alnylam Pharmaceuticals

FMR
BlackRock
Capital World Investors
Capital Research Global Investors
Vanguard Portfolio Management
Vanguard Capital Management
Invesco
State Street Corporation
Jpmorgan Chase & Co
Geode Capital Management
Baillie Gifford & Co
Norges Bank Investment Management
Wellington Management Company
Orbis Allan Gray
Dodge & Cox

View all funds holding Alnylam Pharmaceuticals